During the upcoming Society of Immunotherapy in Cancer (SITC) 2025 Annual Meeting, held November 7-9, 2025, and during the American Society of Hematology (ASH)...
Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat autoimmune and oncology diseases, today announced upcoming presentations at the 67th American Society...
Recordati Rare Diseases Inc. today announced the presentation of new data related to its growing portfolio of treatments for rare hematologic disorders at the...